Takata being sued in the US over dangerous airbags
Takata, the Japanese airbag manufacturer, and various carmakers that use its products, are being sued in the US because of allegations that its cars...
CPPIB multi-million Brazilian real estate investment announced
A multi-million Brazilian real estate investment plan has been announced by Canada Pension Plan Investment Board (CPPIB). The 1 billion real ($396 million) decision...
BP third-quarter profit down 19 percent to $3 billion
London-based BP plc posted a third-quarter profit of $3 billion on Tuesday, which was 19% lower than last-year's third-quarter of $3.7 billion. The company...
Lloyds to close 200 branches and cut 9000 jobs
Lloyds Banking Group reiterated its plan to close 200 branches and cut 9,000 jobs, just two days after finding out it had just scraped...
Twitter reports strong sales and a 23% increase in active users
Twitter sales more than doubled in the third quarter, rising by 114% to $361 million. The social media giant also reported a 23% increase in...
Pietro Cordova replacing Anthony Lacavera as Wind Mobile CEO
Anthony Lacavera is stepping down as the chief executive officer of Wind Mobile, with Pietro Cordova taking his place.
Mr. Cordova has been the company's...
British retail sales strong in October, with continued growth forecast, CBI
UK retail sales volumes in October continued to grow strongly, according to a report by the Confederation of British Industry (CBI) on Monday, with...
Brazilians clinch Chiquita takeover deal worth $682 million
Two Brazilian companies, Grupo Cutrale and Safra Group have clinched a $682 billion deal to acquire Chiquita Brands International Inc. The Charlotte-based banana seller...
Poor railway accident reporting warning by Canadian regulator
On Monday, the Transportation Safety Board of Canada (TSB) warned three railway companies that their reporting of safety issues was inadequate. A seven-year review...
Valeant to raise Allergan bid to 200 dollars per share
Valeant Pharmaceuticals Inc. says it is willing to raise its bid for Allergan Inc. to $200 or perhaps more per share, which would be...